相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human plasma
Esam I. Azhar et al.
VOX SANGUINIS (2021)
Assessing the inactivation capabilities of two commercially available platelet component pathogen inactivation systems: effectiveness at end of shelf life
Carl P. McDonald et al.
VOX SANGUINIS (2021)
Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light
Izabela Ragan et al.
PLOS ONE (2020)
Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light
Marion C. Lanteri et al.
TRANSFUSION (2020)
Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment
Shawn D. Keil et al.
VOX SANGUINIS (2020)
SARS-CoV-2 RNAemia in a Healthy Blood Donor 40 Days After Respiratory Illness Resolution
Tho D. Pham et al.
ANNALS OF INTERNAL MEDICINE (2020)
No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation
Pierre Cappy et al.
BLOOD (2020)
Platelets Can Associate With SARS-CoV-2 RNA and Are Hyperactivated in COVID-19
Younes Zaid et al.
CIRCULATION RESEARCH (2020)
SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
Si Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Development and Optimization of In-house ELISA for Detection of Human IgG Antibody to SARS-CoV-2 Full Length Spike Protein
Thamir A. Alandijany et al.
PATHOGENS (2020)
Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations
Le Chang et al.
EMERGING INFECTIOUS DISEASES (2020)
Amotosalen and ultraviolet A light efficiently inactivate MERS-coronavirus in human platelet concentrates
A. M. Hashem et al.
TRANSFUSION MEDICINE (2019)
Inactivation of Middle East respiratory syndrome-coronavirus in human plasma using amotosalen and ultraviolet A light
Salwa I. Hindawi et al.
TRANSFUSION (2018)
Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion-associated graft-versus-host disease
Grace Castro et al.
TRANSFUSION (2018)
Impact of platelet pathogen inactivation on blood component utilization and patient safety in a large Austrian Regional Medical Centre
M. Amato et al.
VOX SANGUINIS (2017)
Prevention of transfusion-associated graft-versus-host disease with pathogen-reduced platelets with amotosalen and ultraviolet A light: a review
J. Cid
VOX SANGUINIS (2017)
Evaluation of the effectiveness of a pathogen inactivation technology against clinically relevant transfusion-transmitted bacterial strains
Michael Schmidt et al.
TRANSFUSION (2015)
Pathogen Inactivation Technologies for Cellular Blood Components: an Update
Peter Schlenke
TRANSFUSION MEDICINE AND HEMOTHERAPY (2014)
Therapeutic efficacy of platelet components treated with amotosalen and ultraviolet A pathogen inactivation method: results of a meta-analysis of randomized controlled trials
J. Cid et al.
VOX SANGUINIS (2012)
Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination
Lynette Sawyer et al.
TRANSFUSION (2007)
Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function
Yasmin Singh et al.
TRANSFUSION (2006)
Amotosalen photochemical inactivation of severe acute respiratory syndrome coronavirus in human platelet concentrates
D Pinna et al.
TRANSFUSION MEDICINE (2005)
分享论文
